Comparing clinical effectiveness and drug toxicity with hydrochlorothiazide and chlorthalidone using two potency ratios in a managed care population.

about

S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.

P2860

Q55312135-1DE252E2-4D9F-4C59-AC25-F29F7778C469

P2860

Comparing clinical effectiveness and drug toxicity with hydrochlorothiazide and chlorthalidone using two potency ratios in a managed care population.

Item

http://www.wikidata.org/entity/Q41703861

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Comparing clinical effectivene ...... in a managed care population.

@en

type

Item

label

Comparing clinical effectivene ...... in a managed care population.

@en

prefLabel

Comparing clinical effectivene ...... in a managed care population.

@en

P1476

Comparing clinical effectivene ...... s in a managed care population

@en

P2093

Kavita V Nair

http://www.w3.org/2001/XMLSchema#string

Vahram Ghushchyan

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability.

Hypertension and coronary artery disease: a summary of the American Heart Association scientific statement.

Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate.

P304

134-140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JCH.12453

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joseph J Saseen

P577

2014-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25496048

http://www.w3.org/2001/XMLSchema#string

Comparing clinical effectiveness and drug toxicity with hydrochlorothiazide and chlorthalidone using two potency ratios in a managed care population.

about

P2860

P2860

Comparing clinical effectiveness and drug toxicity with hydrochlorothiazide and chlorthalidone using two potency ratios in a managed care population.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698